{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T22:55:34Z","timestamp":1772578534974,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"vor","delay-in-days":366,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation","award":["TCRD-I101-02"],"award-info":[{"award-number":["TCRD-I101-02"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","jfma-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jfma.2015.07.004","type":"journal-article","created":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T15:53:32Z","timestamp":1439481212000},"page":"923-928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase\/platelet ratio index in chronic hepatitis C patients"],"prefix":"10.1016","volume":"114","author":[{"given":"Chia-Chi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pin-Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai-Chung","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Hsienhong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Horng","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2015.07.004_bib1","doi-asserted-by":"crossref","first-page":"E91","DOI":"10.1046\/j.1440-1746.2000.02108.x","article-title":"Transmission of hepatitis C virus in Asia: past and present perspectives","volume":"15","author":"Kao","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2015.07.004_bib2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/hep.24500","article-title":"Fighting against viral hepatitis: lessons from Taiwan","volume":"54","author":"Chen","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2015.07.004_bib3","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1136\/gut.34.2_Suppl.S13","article-title":"Epidemiology and long term prognosis of hepatitis C virus infection in Japan","volume":"34","author":"Yano","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.jfma.2015.07.004_bib4","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/hep.21440","article-title":"Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: lessons from the HALT-C trial","volume":"44","author":"Everson","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2015.07.004_bib5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jfma.2014.05.007","article-title":"A pilot study of add-on oral hypoglycemic agents in treatment-na\u00efve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin","volume":"113","author":"Hsu","year":"2014","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2015.07.004_bib6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJM200102153440706","article-title":"Liver biopsy","volume":"344","author":"Bravo","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2015.07.004_bib7","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","article-title":"Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection","volume":"97","author":"Regev","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jfma.2015.07.004_bib8","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.cgh.2007.07.020","article-title":"Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis","volume":"5","author":"Talwalkar","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2015.07.004_bib9","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2215\/CJN.04320510","article-title":"Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients","volume":"6","author":"Liu","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2015.07.004_bib10","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/hep.21835","article-title":"Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review","volume":"46","author":"Shaheen","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2015.07.004_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ki.2010.74","article-title":"The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C","volume":"78","author":"Liu","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2015.07.004_bib12","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2015.07.004_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2015.07.004_bib14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.transproceed.2008.12.014","article-title":"APRI and FIB-4 scores are useful after liver transplantation independently of etiology","volume":"41","author":"Pissaia","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jfma.2015.07.004_bib15","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/ajg.2009.746","article-title":"Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection","volume":"105","author":"Nunes","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jfma.2015.07.004_bib16","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1086\/592579","article-title":"Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial","volume":"47","author":"Liu","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jfma.2015.07.004_bib17","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1478-3231.2006.01355.x","article-title":"Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases","volume":"26","author":"Liu","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.jfma.2015.07.004_bib18","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.cgh.2007.07.017","article-title":"Noninvasive diagnosis of hepatic fibrosis in patients with chronic hepatitis C by splenic Doppler impedance index","volume":"5","author":"Liu","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2015.07.004_bib19","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1148\/radiology.148.3.6878708","article-title":"A method of comparing the areas under receiver operating characteristic curves derived from the same cases","volume":"148","author":"Hanley","year":"1983","journal-title":"Radiology"},{"key":"10.1016\/j.jfma.2015.07.004_bib20","doi-asserted-by":"crossref","first-page":"807","DOI":"10.7326\/0003-4819-158-11-201306040-00005","article-title":"Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review","volume":"158","author":"Chou","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jfma.2015.07.004_bib21","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/hep.23425","article-title":"Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations","volume":"51","author":"Cast\u00e9ra","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2015.07.004_bib22","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2893.2006.00811.x","article-title":"Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases","volume":"14","author":"Coco","year":"2007","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jfma.2015.07.004_bib23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1440-1746.2010.06510.x","article-title":"Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population","volume":"26","author":"Wong","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2015.07.004_bib24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2893.2012.01635.x","article-title":"Noninvasive estimation of fibrosis progression overtime using the FIB-4 index in chronic hepatitis C","volume":"20","author":"Tamaki","year":"2013","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jfma.2015.07.004_bib25","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.3748\/wjg.v16.i45.5710","article-title":"Role of simple biomarkers in predicting fibrosis progression in HCV infection","volume":"16","author":"Mummadi","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jfma.2015.07.004_bib26","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"Lin","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2015.07.004_bib27","doi-asserted-by":"crossref","first-page":"e6718","DOI":"10.5812\/hepatmon.6718","article-title":"Non-invasive prediction of hepatic fibrosis in patients with chronic HCV based on the routine pre-treatment workup","volume":"12","author":"Khairy","year":"2012","journal-title":"Hepat Mon"},{"key":"10.1016\/j.jfma.2015.07.004_bib28","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/cid\/cit245","article-title":"Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort","volume":"57","author":"Holmberg","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jfma.2015.07.004_bib29","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/j.1478-3231.2008.01789.x","article-title":"Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C","volume":"28","author":"Cal\u00e8s","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.jfma.2015.07.004_bib30","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/jvh.12224","article-title":"The validity of serum markers for fibrosis staging in chronic hepatitis B and C","volume":"21","author":"Li","year":"2014","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jfma.2015.07.004_bib31","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664615002417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664615002417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:10:15Z","timestamp":1748563815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664615002417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0929664615002417"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2015.07.004","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase\/platelet ratio index in chronic hepatitis C patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2015.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier (Singapore) Pte Ltd.","name":"copyright","label":"Copyright"}]}}